Clincosm LogoSign in Get a demo

Rheumatoid Arthritis

Showing NaN - NaN of 110
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rheumatoid Arthritis, Arthritis, Rheumatoid, Arthritis Trial in United States (Imvotamab, Placebo)

Recruiting
  • Rheumatoid Arthritis
  • +2 more
  • Anniston, Alabama
  • +6 more
Oct 11, 2023

Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Adalimumab, Upadacitinib Matching Placebo)

Not yet recruiting
  • Rheumatoid Arthritis
  • Flagstaff, Arizona
  • +190 more
Apr 4, 2023

Advanced Malignant Solid Tumor, Autoimmune Disease, Crohn Disease Trial in Canada, United States (Nivolumab)

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +15 more
  • Biospecimen Collection
  • Nivolumab
  • Birmingham, Alabama
  • +46 more
Jan 31, 2023

Rheumatoid Arthritis Trial in United States (ATI-450 50mg oral tablet BID, Placebo oral tablet, Methotrexate)

Recruiting
  • Rheumatoid Arthritis
  • ATI-450 50mg oral tablet BID
  • +3 more
  • El Cajon, California
  • +24 more
Jan 27, 2023

Rheumatoid Arthritis (RA) Trial in Worldwide (NI-071, Infliximab)

Completed
Has Results
  • Rheumatoid Arthritis
  • Little Rock, Arkansas
  • +133 more
Jan 26, 2023

Rheumatoid Arthritis Trial in United States (Baricitinib, TNF Inhibitor)

Recruiting
  • Rheumatoid Arthritis
  • Flagstaff, Arizona
  • +108 more
Jan 17, 2023

Autoimmune Disorder, Rheumatoid Arthritis, Systemic Lupus Erythematosus Trial in Worldwide (branebrutinib, abatacept,

Completed
  • Autoimmune Disorder
  • +3 more
  • Phoenix, Arizona
  • +80 more
Dec 16, 2022

Chronic Disease Management, Rheumatoid Arthritis Trial in Houston (Questionnaires, Facebook, Educational Website)

Active, not recruiting
  • Chronic Disease Management
  • Rheumatoid Arthritis
  • Questionnaires
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 9, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo to Upadacitinib, Methotrexate, Placebo to Methotrexate)

Completed
Has Results
  • Rheumatoid Arthritis
  • Placebo to Upadacitinib
  • +3 more
  • La Mesa, California
  • +289 more
Dec 1, 2022

Testing ofEducational Tool for Melanoma and Pre-Existing

Recruiting
  • Ankylosing Spondylitis
  • +12 more
  • Best Practice
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 20, 2022

Rheumatoid Arthritis Trial in Worldwide (Methotrexate, Upadacitinib, Placebo Upadacitinib)

Completed
Has Results
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +152 more
Aug 30, 2022

Rheumatoid Arthritis, Systemic Lupus Erythematosus (SLE), Pemphigus Vulgaris Trial in United States (Moderna mRNA-1273,

Recruiting
  • Rheumatoid Arthritis
  • +8 more
  • Moderna mRNA-1273
  • +5 more
  • Los Angeles, California
  • +24 more
Aug 17, 2022

Degenerative Arthritis, Radial Head Fracture, Rheumatoid Arthritis Trial in United States (Carbon Modular Radial Head

Terminated
  • Degenerative Arthritis
  • +2 more
  • Carbon Modular Radial Head replacement
  • Metal Radial Head replacement
  • Gainesville, Florida
  • +3 more
Aug 9, 2022

Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Pneumococcal 13-valent conjugate vaccine (PCV-13))

Completed
Has Results
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +123 more
Jun 15, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo for Adalimumab, Adalimumab, Placebo for Upadacitinib)

Active, not recruiting
Has Results
  • Rheumatoid Arthritis
  • Placebo for Adalimumab
  • +3 more
  • Birmingham, Alabama
  • +369 more
Jun 14, 2022

Rheumatoid Arthritis Trial in United States (Experimental: Arm A: DRL_RI, Arm B: Rituxan®/Mabthera®)

Active, not recruiting
  • Rheumatoid Arthritis
  • Experimental: Arm A: DRL_RI
  • Arm B: Rituxan®/Mabthera®
  • Phoenix, Arizona
  • +25 more
Apr 6, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo, Upadacitinib)

Completed
Has Results
  • Rheumatoid Arthritis
  • Mesa, Arizona
  • +166 more
Mar 17, 2022

Rheumatoid Arthritis Trial in Worldwide (SAR153191 (REGN88))

Completed
Has Results
  • Rheumatoid Arthritis
  • SAR153191 (REGN88)
  • Anniston, Alabama
  • +334 more
Mar 21, 2022

Rheumatoid Arthritis Trial in Worldwide (Upadacitinib, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +187 more
Feb 14, 2022

Rheumatoid Arthritis Trial in Worldwide (Placebo, Upadacitinib)

Completed
Has Results
  • Rheumatoid Arthritis
  • Hemet, California
  • +62 more
Jul 28, 2021

Rheumatoid Arthritis Trial in Worldwide (Olokizumab, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • Glendale, Arizona
  • +164 more
Jun 30, 2021

Rheumatoid Arthritis Trial in Worldwide (Abatacept, Methotrexate, Abatacept Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +200 more
Jun 25, 2021

Rheumatoid Arthritis Trial in Worldwide (Olokizumab 64mg q4w, Olokizumab 64mg q2w, Adalimumab 40mg q2w)

Completed
Has Results
  • Rheumatoid Arthritis
  • Olokizumab 64mg q4w
  • +3 more
  • Mesa, Arizona
  • +244 more
Apr 6, 2021

Rheumatoid Arthritis Trial in Worldwide (GLPG0634, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • Gilbert, Arizona
  • +81 more
Nov 24, 2020

Rheumatoid Arthritis Trial in Worldwide (GLPG0634, Placebo)

Completed
Has Results
  • Rheumatoid Arthritis
  • Huntsville, Alabama
  • +141 more
Oct 26, 2020